MRI of the liver: choosing the right contrast agent

Christopher L. Welle, Flavius F. Guglielmo, Sudhakar K Venkatesh

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Contrast enhanced MRI of the liver provides valuable information in the evaluation of both chronic liver disease and focal liver lesions. Currently, two classes of MRI contrast agents are available for clinical use, namely the extracellular contrast agent (ECA) and the hepatobiliary agent (HBA). The use of appropriate contrast agents for liver MRI requires knowledge of the clinical situation and question to be answered. ECAs have been used for decades since their introduction into clinical practice and provide excellent dynamic phase information that is useful in characterizing focal liver lesions. In the last decade, HBAs, particularly Gadoxetate, have been found useful for characterizing lesions with functioning hepatocytes and more importantly in evaluating the biliary tree. Gadoxetate, however, provides less satisfactory dynamic phase images compared to ECAs, particularly during the arterial phase. In this perspective article, we will discuss the various intravenous contrast agents used for liver MRI and their ideal utilization.

Original languageEnglish (US)
JournalAbdominal Radiology
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Contrast Media
Liver
Biliary Tract
Liver Diseases
Hepatocytes
Chronic Disease

Keywords

  • Biliary tree
  • Extracellular contrast agents
  • Gadobenate dimeglumine
  • Gadolinium-based contrast agents
  • Gadoxetate disodium
  • Hepatobiliary contrast agents

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology
  • Radiology Nuclear Medicine and imaging
  • Gastroenterology
  • Urology

Cite this

MRI of the liver : choosing the right contrast agent. / Welle, Christopher L.; Guglielmo, Flavius F.; Venkatesh, Sudhakar K.

In: Abdominal Radiology, 01.01.2019.

Research output: Contribution to journalReview article

@article{610c48d393e641b1b6827fd6e1a0e4e5,
title = "MRI of the liver: choosing the right contrast agent",
abstract = "Contrast enhanced MRI of the liver provides valuable information in the evaluation of both chronic liver disease and focal liver lesions. Currently, two classes of MRI contrast agents are available for clinical use, namely the extracellular contrast agent (ECA) and the hepatobiliary agent (HBA). The use of appropriate contrast agents for liver MRI requires knowledge of the clinical situation and question to be answered. ECAs have been used for decades since their introduction into clinical practice and provide excellent dynamic phase information that is useful in characterizing focal liver lesions. In the last decade, HBAs, particularly Gadoxetate, have been found useful for characterizing lesions with functioning hepatocytes and more importantly in evaluating the biliary tree. Gadoxetate, however, provides less satisfactory dynamic phase images compared to ECAs, particularly during the arterial phase. In this perspective article, we will discuss the various intravenous contrast agents used for liver MRI and their ideal utilization.",
keywords = "Biliary tree, Extracellular contrast agents, Gadobenate dimeglumine, Gadolinium-based contrast agents, Gadoxetate disodium, Hepatobiliary contrast agents",
author = "Welle, {Christopher L.} and Guglielmo, {Flavius F.} and Venkatesh, {Sudhakar K}",
year = "2019",
month = "1",
day = "1",
doi = "10.1007/s00261-019-02162-5",
language = "English (US)",
journal = "Abdominal Radiology",
issn = "2366-004X",
publisher = "Springer New York",

}

TY - JOUR

T1 - MRI of the liver

T2 - choosing the right contrast agent

AU - Welle, Christopher L.

AU - Guglielmo, Flavius F.

AU - Venkatesh, Sudhakar K

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Contrast enhanced MRI of the liver provides valuable information in the evaluation of both chronic liver disease and focal liver lesions. Currently, two classes of MRI contrast agents are available for clinical use, namely the extracellular contrast agent (ECA) and the hepatobiliary agent (HBA). The use of appropriate contrast agents for liver MRI requires knowledge of the clinical situation and question to be answered. ECAs have been used for decades since their introduction into clinical practice and provide excellent dynamic phase information that is useful in characterizing focal liver lesions. In the last decade, HBAs, particularly Gadoxetate, have been found useful for characterizing lesions with functioning hepatocytes and more importantly in evaluating the biliary tree. Gadoxetate, however, provides less satisfactory dynamic phase images compared to ECAs, particularly during the arterial phase. In this perspective article, we will discuss the various intravenous contrast agents used for liver MRI and their ideal utilization.

AB - Contrast enhanced MRI of the liver provides valuable information in the evaluation of both chronic liver disease and focal liver lesions. Currently, two classes of MRI contrast agents are available for clinical use, namely the extracellular contrast agent (ECA) and the hepatobiliary agent (HBA). The use of appropriate contrast agents for liver MRI requires knowledge of the clinical situation and question to be answered. ECAs have been used for decades since their introduction into clinical practice and provide excellent dynamic phase information that is useful in characterizing focal liver lesions. In the last decade, HBAs, particularly Gadoxetate, have been found useful for characterizing lesions with functioning hepatocytes and more importantly in evaluating the biliary tree. Gadoxetate, however, provides less satisfactory dynamic phase images compared to ECAs, particularly during the arterial phase. In this perspective article, we will discuss the various intravenous contrast agents used for liver MRI and their ideal utilization.

KW - Biliary tree

KW - Extracellular contrast agents

KW - Gadobenate dimeglumine

KW - Gadolinium-based contrast agents

KW - Gadoxetate disodium

KW - Hepatobiliary contrast agents

UR - http://www.scopus.com/inward/record.url?scp=85070230167&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070230167&partnerID=8YFLogxK

U2 - 10.1007/s00261-019-02162-5

DO - 10.1007/s00261-019-02162-5

M3 - Review article

AN - SCOPUS:85070230167

JO - Abdominal Radiology

JF - Abdominal Radiology

SN - 2366-004X

ER -